These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3228488)

  • 1. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinin release from human LMW-kininogen by the cooperative action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Adv Exp Med Biol; 1989; 247A():493-8. PubMed ID: 2603815
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
    Fujie H; Hayashi I; Oh-ishi S
    Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.
    Kleniewski J; Donaldson V
    J Exp Med; 1988 Jun; 167(6):1895-907. PubMed ID: 3260266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens.
    Kozik A; Moore RB; Potempa J; Imamura T; Rapala-Kozik M; Travis J
    J Biol Chem; 1998 Dec; 273(50):33224-9. PubMed ID: 9837892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new kinin moiety in human plasma kininogens.
    Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
    Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serine proteinases isolated from rat submaxillary gland: with special reference to the degradation of rat kininogens by these enzymes.
    Kato H; Nakanishi E; Enjyoji K; Hayashi I; Oh-ishi S; Iwanaga S
    J Biochem; 1987 Dec; 102(6):1389-404. PubMed ID: 3482210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylated kininogens and kinins.
    Kato H; Enjyoji K
    Agents Actions Suppl; 1992; 38 ( Pt 1)():217-24. PubMed ID: 1334619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.
    Mori K; Nagasawa S
    J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in PMN-elastase in blood and in renal and plasma kallikrein-kinin systems after severe burn injury.
    Bönner G; Niermann W; Festge R; Büchsler U
    Adv Exp Med Biol; 1988; 240():499-503. PubMed ID: 2469308
    [No Abstract]   [Full Text] [Related]  

  • 17. [Purification of kininogen II (LMW) from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):243-7. PubMed ID: 1032267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
    Kleniewski J; Donaldson VH
    J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins.
    Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S
    J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
    Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
    Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.